Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
This image was generated by AI and may not depict real events.
Helus Pharma has appointed Dr. Ken Kramer as Senior Vice President, Medical Affairs, to strengthen its medical leadership and advance its pipeline of novel serotonergic agonists. Dr. Kramer brings over 25 years of experience in neuroscience and medical affairs leadership.
Helus Pharma, a clinical-stage pharmaceutical company, has appointed Dr. Ken Kramer as Senior Vice President, Medical Affairs. Dr. Kramer has over 25 years of experience in neuroscience and medical affairs leadership, most recently serving as Vice President and Head of Medical Neuroscience at Bristol Myers Squibb. He led the launch of a new schizophrenia treatment and has experience building medical capabilities during organizational growth. Dr. Kramer will help Helus scale its medical capabilities and advance its pipeline of novel serotonergic agonists. Helus is developing treatments for depression, anxiety, and other mental health conditions. The company's lead candidate, HLP003, is in Phase 3 clinical development for major depressive disorder and has received Breakthrough Therapy Designation from the US FDA.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.